2Suppliers
0Customers
2Debt Items
0Related Chains
Amylyx Pharmaceuticals, Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
|---|
| CMOS |
CMOS |
80%
|
expenses incurred under agreements with CROs, CMOs, as well as investigative sites and consultants that conduct our clinical trials |
| CROS |
CROS |
80%
|
expenses incurred under agreements with CROs, CMOs, as well as investigative sites and consultants that conduct our clinical trials |
Amylyx Pharmaceuticals, Inc. Customers
No clients on recordNo downstream customers found in our database for Amylyx Pharmaceuticals, Inc..
Amylyx Pharmaceuticals, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| AMLX-DEBT-7729 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2022-12-31. |
| AMLX-DEBT |
Debt stack $5.6M |
90%
|
Market cache reports total debt of $5.6M. |
Amylyx Pharmaceuticals, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Amylyx Pharmaceuticals, Inc..
Amylyx Pharmaceuticals, Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| AMLX-OWNER-FMR-LLC |
FMR LLC |
90%
|
13F overlay lists FMR LLC as top holder; 174 tracked holders. |
Amylyx Pharmaceuticals, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
